Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
236.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (3.448%)
Market Cap: £57.68m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Director Shareholding , Share cap and share match

7 Apr 2015 07:00

RNS Number : 3951J
EPE Special Opportunities PLC
02 April 2015
 



 

EPE Special Opportunities plc

 

Director/PDMR Shareholding, Share Capital Update and Share Matching Plan Award

 

 

EPE Special Opportunities plc ("ESO plc" or the "Company") announces that on the 1 April 2015 it purchased 522,914 shares of 5 pence each ("Ordinary Shares") at an average price of 110 pence per share. The Ordinary Shares were purchased by a wholly owned subsidiary of the Company, Corvina Limited. The repurchased Ordinary Shares may be held and resold as if they were Treasury Shares.

 

The number of Ordinary Shares in issue following this transaction is 28,178,558 (including 1,191,280 shares held by the Employee Benefit Trust which have traditionally not voted) and is the figure to be used as the denominator for calculations of interests in the Company's voting rights.

 

The Company also announces that on 1 April 2015 the Company made further awards under the Share Matching Plan. Awards of Matching Shares totalling 263,952 were made with shares expected to be purchased out of Treasury shortly by the Employee Benefit Trust (established under the Share Matching Plan) to satisfy the awards. All of the awards were made to Eligible Participants including Giles Brand (awards made over 27,273 shares) and four Directors of the Company, Geoffrey Vero (awards made over 18,182 shares), Clive Spears (awards made over 6,818 shares), Nicholas Wilson (awards made over 6,818 shares) and Robert Quayle (awards made over 6,818 shares).

 

Giles Brand (the Managing Partner of EPIC Private Equity LLP which is the Investment Advisor to the Company) and his connected persons purchased 27,199 Ordinary Shares in the market and now hold 6,337,905 Ordinary Shares representing 22.49% of the issued Ordinary Share capital of the Company.

 

Geoffrey Vero purchased 18,182 Ordinary Shares in the market and now holds 78,802 Ordinary Shares representing 0.28% of the issued Ordinary Share capital of the Company.

 

Nicholas Wilson purchased 6,818 Ordinary Shares in the market and now holds 64,892 Ordinary Shares representing 0.23% of the issued Ordinary Share capital of the Company.

 

Clive Spears purchased 7,500 Ordinary Shares in the market and now holds 45,255 Ordinary Shares representing 0.16% of the issued Ordinary Share capital of the Company.

 

Robert Quayle purchased 6,818 Ordinary Shares in the market and now holds 44,573 Ordinary Shares representing 0.16% of the issued Ordinary Share capital of the Company.

 

All of the above trades were made at a price of 110 pence per Ordinary Share.

 

 

 

Enquiries:

 

EPIC Private Equity LLP

Alex Leslie

+44 (0) 20 7269 8865

IOMA Fund and Investment Management Limited

Philip Scales

+44 (0) 1624 681250

Numis Securities Ltd

+44 (0) 20 7260 1000

Nominated Advisor:

Stuart Skinner / Hugh Jonathan

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAPLAEFDSEFF
Date   Source Headline
25th Jun 20268:56 amRNSTransaction in Own Shares
23rd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20267:00 amRNSRecommencement of Share Buy Backs
5th Jun 20265:20 pmRNSUpdate on Share Buy Backs
5th Jun 20267:00 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:00 pmRNSHolding(s) in Company
1st Jun 20264:25 pmRNSTransaction in Own Shares
1st Jun 20267:00 amRNSAnnouncement of Share Buy Backs
29th May 20261:30 pmRNSDirector/PDMR Shareholding
27th May 20264:00 pmRNSPartial Sell Down of Investment in Luceco plc
8th May 20267:00 amRNSNet Asset Value(s)
28th Apr 20265:05 pmRNSHolding(s) in Company
28th Apr 20265:00 pmRNSDirector/PDMR Shareholding
28th Apr 20267:15 amRNSDirector/PDMR Shareholding
23rd Apr 20267:15 amRNSHolding(s) in Company
16th Apr 20262:50 pmRNSHolding(s) in Company
16th Apr 20262:45 pmRNSDirector/PDMR Shareholding
15th Apr 20269:12 amRNSNet Asset Value(s)
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSAnnual Financial Report
20th Feb 20266:22 pmRNSUpdate on Share Buy Backs
18th Feb 20261:00 pmRNSTransaction in Own Shares
17th Feb 20265:10 pmRNSHolding(s) in Company
17th Feb 20265:00 pmRNSHolding(s) in Company
17th Feb 20261:35 pmRNSTransaction in Own Shares
13th Feb 20267:00 amRNSAnnouncement of Share Buy Backs
9th Feb 20267:00 amRNSTrading Statement
4th Feb 20267:00 amRNSInterest Payment on Unsecured Loan Notes
15th Jan 20267:00 amRNSNet Asset Value(s)
22nd Dec 20257:00 amRNSUpdate on Share Buy Backs
22nd Dec 20257:00 amRNSUpdate on Share Buy Backs
11th Dec 20257:00 amRNSNet Asset Value(s)
4th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:03 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:08 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSNet Asset Value(s)
13th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.